Health IT company Medstreaming, maker of a clinical data management platform for image-intensive medical specialties, is looking to raise $200,000 to fund an unspecified acquisition. It’s an oddly small number for a company that’s been around for 10 years in this cash-intensive industry.
Medstreaming, based in Redmond, Washington, disclosed the fundraise in a Form D filed Wednesday with the U.S. Securities and Exchange Commission.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“This transaction isn’t related to equity fundraising,” Medstreaming General Counsel Mohammed Khalil said. “It’s related to an acqusition.” He said it was a “small acquisition,” but wouldn’t name the target company or give a timeline for closing the deal.
Khalil talked to MedCity News after we tried reaching Medstreaming COO Michael Thompson. When asked about the Form D filing, Thompson said, “I’m not aware of what you’re talking about,” then promptly hung up.
Medstreaming makes specialty electronic health records, picture archiving and communication systems and other imaging management, analytics and billing software. The company seems particularly focused on cardiovascular information systems.
In October, Medstreaming landed an unspecified investment from Third Core, the investment arm of Sentara Healthcare, Norfolk, Virginia. As a result, two Sentara executives joined Medstreaming’s board.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Photo: Medstreaming
